Menu

How Bacteria in Flies Kill Parasitic Wasps

Ribosome-inactivating proteins from symbiotic bacteria leave their hosts unharmed.

Jul 10, 2017
Shawna Williams

A female parasitic wasp inserts her ovipositor into a Drosophila larva to lay her egg.MICHAEL MARTIN, REED COLLEGE. COURTESY: NATIONAL SCIENCE FOUNDATIONA strain of the symbiotic Spiroplasma bacteria protects its host fly by producing a toxin that attacks the ribosomes of parasitic wasps, researchers reported July 6 in PLOS Pathogens. The study builds on the finding that another Spiroplasma strain defends against parasitic nematodes in the same way.

Spiroplasma bacteria are thought to live in at least 7 percent of insects, where they are passed down from mother to young, write the researchers in their report. In the lab, Spiroplasma-infected Drosophila have proven more resistant than their uninfected counterparts to pests such as parasitic wasps, which lay eggs in Drosophila larvae.

Until recently, scientists had few clues as to how the bacterial protection worked. Then, in 2013, a research group led by Steve Perlman of the University of Victoria found that Spiroplasma in one Drosophila species make a ribosome-inactivating protein that is toxic to would-be parasitic nematodes. Other known ribosome-inactivating proteins, fittingly abbreviated as RIPs, include the deadly ricin made famous by Breaking Bad and the Shiga toxin deployed by pathogenic E. coli bacteria.

Perlman and a colleague now report that in the Spiroplasma strain that affects wasps, similar RIPs are deployed to cleave a specific adenine residue from the parasite’s ribosomal RNA, disabling it. Without working ribosomes, the wasps die soon after hatching. But the toxins leave Drosophila ribosomes untouched.

“The symbiont has figured out how to target two dissimilar parasites without harming its host,” first author Matt Ballinger of the University of Victoria says in a statement. “We want to know how it does this, and we think an important clue is that Spiroplasma strains are collecting lots of different toxin genes in their tiny genomes.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.